Watson Calls On High Court To Support 'Pay-For-Delay' Deals
Watson Pharmaceuticals Inc. on Tuesday agreed with the Federal Trade Commission that the U.S. Supreme Court should consider the agency's antitrust challenge to "pay-for-delay" drug patent settlements, but told the high...To view the full article, register now.
Already a subscriber? Click here to view full article